Sylvain Larroque

436 total citations
12 papers, 287 citations indexed

About

Sylvain Larroque is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, Sylvain Larroque has authored 12 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 4 papers in Physiology and 3 papers in Genetics. Recurrent topics in Sylvain Larroque's work include Erythropoietin and Anemia Treatment (4 papers), Hemoglobinopathies and Related Disorders (3 papers) and Lysosomal Storage Disorders Research (3 papers). Sylvain Larroque is often cited by papers focused on Erythropoietin and Anemia Treatment (4 papers), Hemoglobinopathies and Related Disorders (3 papers) and Lysosomal Storage Disorders Research (3 papers). Sylvain Larroque collaborates with scholars based in Germany, Switzerland and United States. Sylvain Larroque's co-authors include Michael Beck, Christoph Kampmann, Guillem Pintos‐Morell, Anna Wijatyk, Atul Mehta, Michael L. West, Uma Ramaswami, Derralynn Hughes, Roberto Giugliani and Mauro Bozzola and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Osteoarthritis and Cartilage.

In The Last Decade

Sylvain Larroque

12 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvain Larroque Germany 8 122 63 63 59 43 12 287
Gianluca Tamaro Italy 9 92 0.8× 42 0.7× 72 1.1× 23 0.4× 18 0.4× 32 258
Ivana Capuano Italy 11 142 1.2× 61 1.0× 32 0.5× 46 0.8× 13 0.3× 29 297
Stefanie Reiermann Germany 8 178 1.5× 73 1.2× 12 0.2× 63 1.1× 5 0.1× 11 343
Paolo Pattoneri Italy 9 38 0.3× 24 0.4× 79 1.3× 44 0.7× 85 2.0× 25 342
Colleen Ditro United States 10 95 0.8× 36 0.6× 5 0.1× 69 1.2× 21 0.5× 19 277
Jean-Claude Lubanda Czechia 11 318 2.6× 190 3.0× 6 0.1× 93 1.6× 6 0.1× 27 483
Ryan N. Montalvo United States 13 155 1.3× 46 0.7× 7 0.1× 24 0.4× 6 0.1× 23 412
F Valente Italy 11 54 0.4× 36 0.6× 52 0.8× 7 0.1× 16 0.4× 32 294
Simon Burnet Australia 8 21 0.2× 49 0.8× 43 0.7× 132 2.2× 42 1.0× 15 353
Christopher Denton United States 9 40 0.3× 16 0.3× 96 1.5× 37 0.6× 96 2.2× 30 327

Countries citing papers authored by Sylvain Larroque

Since Specialization
Citations

This map shows the geographic impact of Sylvain Larroque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Larroque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Larroque more than expected).

Fields of papers citing papers by Sylvain Larroque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Larroque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Larroque. The network helps show where Sylvain Larroque may publish in the future.

Co-authorship network of co-authors of Sylvain Larroque

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvain Larroque. A scholar is included among the top collaborators of Sylvain Larroque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvain Larroque. Sylvain Larroque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Macdougall, Iain C., Andreas Böck, Fernando Carrera, et al.. (2017). Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial. BMC Nephrology. 18(1). 24–24. 12 indexed citations
2.
Carrera, Fernando, K-U Eckardt, Sandrine Gaillard, et al.. (2017). MP416EFFICACY OF ORAL IRON FOR TREATING IRON DEFICIENCY IN ANAEMIC PATIENTS WITH NON-DIALYSIS DEPENDENT CKD (ND-CKD). Nephrology Dialysis Transplantation. 32(suppl_3). iii581–iii581. 1 indexed citations
3.
Macdougall, Iain C., Andreas Böck, Fernando Carrera, et al.. (2017). Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial. Clinical Nephrology. 88(12). 301–310. 20 indexed citations
4.
Gaillard, Sandrine, Andreas Böck, Fernando Carrera, et al.. (2016). Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial. PLoS ONE. 11(6). e0157063–e0157063. 28 indexed citations
5.
Roger, Simon D., Andreas Böck, Fernando Carrera, et al.. (2016). SO035THE SAFETY OF INTRAVENOUS (IV) FERRIC CARBOXYMALTOSE (FCM) IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD (ND-CKD): 1-YEAR RESULTS FROM THE FIND-CKD TRIAL. Nephrology Dialysis Transplantation. 31(suppl_1). i15–i16. 1 indexed citations
6.
Floege, Jürgen, Stuart M. Sprague, Adrian Covic, et al.. (2016). MP365SUCROFERRIC OXYHYDROXIDE DOES NOT IMPACT THE IPTH-LOWERING EFFECTS OF ORAL VDRAS OR CINACALCET: A POST HOC ANALYSIS OF A PHASE 3 STUDY. Nephrology Dialysis Transplantation. 31(suppl_1). i461–i461. 2 indexed citations
7.
Floege, Jürgen, Stuart M. Sprague, Anjay Rastogi, et al.. (2016). MP381CHARACTERISTICS OF RESPONDERS AND NON-RESPONDERS TO TREATMENT WITH SUCROFERRIC OXYHYDROXIDE: A POST HOC ANALYSIS OF A PHASE 3 STUDY. Nephrology Dialysis Transplantation. 31(suppl_1). i466–i466. 3 indexed citations
8.
Beck, Michael, Derralynn Hughes, Christoph Kampmann, et al.. (2015). Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis. SHILAP Revista de lepidopterología. 3. 21–27. 92 indexed citations
9.
Pitz, Susanne, Laila Arash, Nesrin Karabul, et al.. (2015). Ocular Signs Correlate Well with Disease Severity and Genotype in Fabry Disease. PLoS ONE. 10(3). e0120814–e0120814. 34 indexed citations
10.
Beck, Michael, Derralynn Hughes, Christoph Kampmann, et al.. (2015). Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis. Molecular Genetics and Metabolism. 114(2). S19–S20. 7 indexed citations
11.
12.
Wirth, W., Sylvain Larroque, Richard Y. Davies, et al.. (2010). Comparison of 1-year vs 2-year change in regional cartilage thickness in osteoarthritis results from 346 participants from the Osteoarthritis Initiative. Osteoarthritis and Cartilage. 19(1). 74–83. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gianluca Tamaro Breakdown of academic impact, for papers by Ivana Capuano Breakdown of academic impact, for papers by Stefanie Reiermann Breakdown of academic impact, for papers by Paolo Pattoneri Breakdown of academic impact, for papers by Colleen Ditro Breakdown of academic impact, for papers by Jean-Claude Lubanda Breakdown of academic impact, for papers by Ryan N. Montalvo Breakdown of academic impact, for papers by F Valente Breakdown of academic impact, for papers by Simon Burnet Breakdown of academic impact, for papers by Christopher Denton
Rankless by CCL
2026